본문 바로가기
KERD
논문KCI 등재

아토피피부염 환자 1035명의 장기간의 한의학적 치료효과에 대한 후향적 연구

Retrospective Study about the Effectiveness of a long-term Korean Medicine Treatment on 1035 Atopic Dermatitis Patients

박건|한수련|서산|조아라
대한한방안이비인후피부과학회 (The Korean Medicine Opthalmology&Otolaryngology&Dermatology Society)|2015.02|한방안이비인후피부과학회지 (The Journal of Korean Medicine Ophthalmology&Otorhinolaryngology&Dermatology)|제28권 제1호|pp. 85-99|DOI http://dx.doi.org/10.6114/jkood.2015.28.1.085

0

조회

0

다운로드

2

인용

0

참고문헌

키워드

Atopic dermatitisKorean Medicine TreatmentObjective SCORAD Index(OSI)Improvement rate
주제분류한의학

초록

Objective : The purpose of this study is to report the effectiveness of a long-term Korean MedicineTreatment on 1035 atopic dermatitis patientsMethods : Objective SCORAD Index(OSI) is used for measuring the degree of atopic dermatitis withphotos of total 1035 atopic dermatitis patients who has visited oriental clinic from January 9, 2011 toOctober 31, 2013. Then, OSI was estimated according to gender, age, period of treatment and intensity. Results : 1. The ratio of male to female was 44.4 : 55.6. All patients were constituted with 26.5% of0~11 year-old group, 15.7% of 12~18 year-old and 57.9% of 19 and more year-old. 2. The ratio of OSI improvement was significantly higher in women than in men after 3 monthtreatment, but there was no significant difference after 6, 9 and 12 months. 3. The OSI improvement of 0~11 year-old group was significantly higher than the other groupsafter 3 month treatment. But at the other periods of treatment, there was no significantlydifference of the improvement among 3 different groups of age. 4. After 3, 6, 9 and 12 month treatment, the score of OSI was significantly lower than beforetreatment. After 12 month treatment, the score of OSI was lowest compared to the otherperiods of treatment. 5. The final OSI score of 87.7% patients was decreased compared to the initial. 6. All patients had been divided with 1.93% of the mild, 22.7% of the moderate and 75.4% ofthe severe by OSI intensity at initial visit. At final visit, the composition of patients waschanged to 14.6% of the mild, 53.7% of the moderate and 31.7% of the severe. 7. The mild patients had got 42.56% of OSI improvement at the final. And the moderate hadgot 37.72% of OSI improvement at the final. 8. The severe patients had got 36.76% of OSI improvement at the final. And 89.2% of thesevere had got decreased final OSI score compared to the initial. Conclusion : There was a definite decreasing of OSI score on the significant rate of Atopic dermatitispatients who had been treated by Korean medicine treatment at least for 3 months.

Abstract

Objective : The purpose of this study is to report the effectiveness of a long-term Korean MedicineTreatment on 1035 atopic dermatitis patientsMethods : Objective SCORAD Index(OSI) is used for measuring the degree of atopic dermatitis withphotos of total 1035 atopic dermatitis patients who has visited oriental clinic from January 9, 2011 toOctober 31, 2013. Then, OSI was estimated according to gender, age, period of treatment and intensity. Results : 1. The ratio of male to female was 44.4 : 55.6. All patients were constituted with 26.5% of0~11 year-old group, 15.7% of 12~18 year-old and 57.9% of 19 and more year-old. 2. The ratio of OSI improvement was significantly higher in women than in men after 3 monthtreatment, but there was no significant difference after 6, 9 and 12 months. 3. The OSI improvement of 0~11 year-old group was significantly higher than the other groupsafter 3 month treatment. But at the other periods of treatment, there was no significantlydifference of the improvement among 3 different groups of age. 4. After 3, 6, 9 and 12 month treatment, the score of OSI was significantly lower than beforetreatment. After 12 month treatment, the score of OSI was lowest compared to the otherperiods of treatment. 5. The final OSI score of 87.7% patients was decreased compared to the initial. 6. All patients had been divided with 1.93% of the mild, 22.7% of the moderate and 75.4% ofthe severe by OSI intensity at initial visit. At final visit, the composition of patients waschanged to 14.6% of the mild, 53.7% of the moderate and 31.7% of the severe. 7. The mild patients had got 42.56% of OSI improvement at the final. And the moderate hadgot 37.72% of OSI improvement at the final. 8. The severe patients had got 36.76% of OSI improvement at the final. And 89.2% of thesevere had got decreased final OSI score compared to the initial. Conclusion : There was a definite decreasing of OSI score on the significant rate of Atopic dermatitispatients who had been treated by Korean medicine treatment at least for 3 months.

참고문헌 (33)

  1. 윤영희, "서울 지역을 대상으로 모집된 성인 아토피피부염 환자의 삶의 질과 경제적 비용 부담에 관한 조사", 한방안이비인후피부과학회지, 23(1), pp.199~214 (2010), 대한한방안이비인후피부과학회
  2. Deckers IAG, "Investigating International Time Trends in the Incidence and Prevalence of Atopic Eczema 1990–2010: A Systematic Review of Epidemiological Studies", PLoS ONE, 7(7), pp.e39803~ (2012)
  3. 손창규, "아토피 환자의 치료선택 경향에 대한 설문연구", 한방안이비인후피부과학회지, 27(1), pp.37~44 (2014), 대한한방안이비인후피부과학회
  4. 서민수, "대한안이비인후피부과학회지에 게재된 아토피 피부염 관련논문에 관한 고찰", 한방안이비인후피부과학회지, 22(3), pp.108~121 (2009), 대한한방안이비인후피부과학회
  5. 한수련, "아토피피부염 환자 511명의 장기간의 한의학적 치료효과에 대한 후향적 연구", 한방안이비인후피부과학회지, 26(3), pp.65~76 (2013), 대한한방안이비인후피부과학회
  6. 박영립, "아토피피부염 학회보고서: 한국인 아토피피부염의 진단기준에 대한 연구", 대한피부과학회지, 44(6), pp.659~663 (2006), 대한피부과학회
  7. European Task Force on Atopic Dermatitis, "Severity Scoring of Atopic Dermatitis: The SCORAD Index, consensus report of th European Task Force on Atopic Dermatitis", Dermatology, 186, pp.23~31 (1993)
  8. Kuntz B, "Clinical validation and guidelines for the SCORAD index;consensus report of th European Task Force on Atopic Dermatitis", Dermatol, 195, pp.10~19 (1997)
  9. Rees JL, "Pruritus: more scratch tha irch", Clin Exp Dermatol, 24, pp.490~493 (1992)
  10. Byung Eui Kim, "Epidermal Barrier in Atopic Dermatitis", Allergy, Asthma & Immunology Research, 4(1), pp.12~16 (2012), 대한천식알레르기학회
  11. College of Oriental Medicine Dermatology&Surgery Textbook Compilation Committee, "Text of Traditional Korean Dermatology&Surgery", Sunwoo, pp.355~356 (2007)
  12. 김계하, "우리나라 성인의 아토피피부염 관련요인: 2008년도 국민건강영양조사 자료를 중심으로", 재활간호학회지, 15(2), pp.83~90 (2012), 한국재활간호학회[DOI]
  13. Yang JH, "Western and Traditional Korean approach in Atopic Dermatitis", J Jeahan Orienl Med Acad, 4(1), pp.416~427 (1999)
  14. 손정민, "제천 지역 소재 초등학교 학생들의 아토피 피부염에 대한 설문조사 연구", 한방안이비인후피부과학회지, 22(2), pp.163~175 (2009), 대한한방안이비인후피부과학회
  15. 이갑석, "아토피피부염의 가려움증: 그 발생기전과 치료", Allergy Asthma & Respiratory Diseases, 2(1), pp.8~15 (2014), 대한 소아알레르기 호흡기학회
  16. 김윤희, "한약을 이용한 아토피 임상연구의 경향에 관한 연구", 대한한방소아과학회지, 26(2), pp.53~61 (2012), 대한한방소아과학회[DOI]
  17. 이해성, "소아 아토피 피부염의 빈도와 원인의 변화 - 10년 전과 비교하여 -", Allergy Asthma & Respiratory Diseases, 12(4), pp.263~281 (2002), 대한 소아알레르기 호흡기학회
  18. 김남권, "성인 만성 아토피 피부염 환자의 삶의 질과 한방 치료비용에 대한 고찰", 한방안이비인후피부과학회지, 23(1), pp.215~223 (2010), 대한한방안이비인후피부과학회
  19. Statistical Analysis of Health Security, "Park IS", Social Security System of Korea, ~, pp.Issue Brief No. 2010-01 (2010)
  20. Park HJ, "Association of blood mercury concentrations with atopic dermatitis in adults: A population-based study in Korea", Environmental Research, 111(4), pp.573~578 (2010)
  21. Peters AS, "Prediction of the incidence, recurrence, and persistence of atopic dermatitis in adolescence : A prospective cohort study", Journal of Allergy and Clinical Immunology, 126(3), pp.590~595 (2010)
  22. Zeppa I, "Atopic dermatitis in adults", Dermatitis, 22(1), pp.40~46 (2011)
  23. 이승자, "여성의 연령에 따른 외모관심도와 피부인식 및 피부관리행동", 한국인체미용예술학회지, 12(1), pp.101~112 (2011), 한국인체미용예술학회
  24. Kim JH, "Current understanding of atopic dermatitis", Pediatr Allergy Respir Dis, 2004(14), pp.12~23 (2004)
  25. Yun HJ, "Clinical study of the classification of oriental medical type of atopic dermatitis", J Dong-Eui Orient Med, 5(1), pp.43~57 (2001)
  26. Freehug Oriental Clinic, "Atopic Revolution, The Project of Body Temperature for Immunity Ⅰ: Theory", pp.108~ (2011), Brilliant Tree
  27. 조중범, "아토피피부염의 중증도 변화에 따른 삶의 질 변화", Allergy Asthma & Respiratory Diseases, 22(1), pp.86~99 (2012), 대한 소아알레르기 호흡기학회[DOI]
  28. 김진혜, "성인 아토피피부염 환자의 삶의 질", 대한피부과학회지, 49(11), pp.983~992 (2011), 대한피부과학회
  29. 황선욱, "아토피피부염 환자의 치료경과에 따른 중증도 평가에서 SCORAD Index와 기계적 측정값과의 상관관계", 대한피부과학회지, 48(4), pp.266~271 (2010), 대한피부과학회
  30. 최인화, "A Clinical Study of Shi Ho Cheong Gan-San on Blood Heat Pattern Atopic Dermatitis: a randomized, double-blind clinical trial", 한방안이비인후피부과학회지, 24(1), pp.96~110 (2011), 대한한방안이비인후피부과학회
  31. 윤대철, "아토피 피부염 환자에서 黃連解毒湯이 함유된 한방화장품에 대한 임상 연구", 동의생리병리학회지, 22(6), pp.1611~1620 (2008), 한의병리학회
  32. 신상호, "升葛湯을 사용한 아토피 피부염 환자에 대한 임상시험", 한방안이비인후피부과학회지, 20(2), pp.199~212 (2007), 대한한방안이비인후피부과학회
  33. 황보준원, "아토피와 알레르기질환이 한국 청소년의 폐기능에 미치는 영향", Allergy Asthma & Respiratory Diseases, 2(2), pp.108~113 (2014), 대한 소아알레르기 호흡기학회

관련 논문AI추천

아토피피부염 환자 511명의 장기간의 한의학적 치료효과에 대한 후향적 연구박건, 서산, 고영협, 이정환, 장진영, 정창환, 조재곤, 한명화, 한수련대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2013 · 제26권 제3호중증 아토피피부염 환자 89명의 한의학적 치료 효과에 대한 후향적 연구박건, 서산, 조아라, 한수련대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2016 · 제29권 제2호영유아 아토피피부염 환자 69명의 한의학적 치료효과에 대한 후향적 연구박건, 서산, 민들레, 한명화, 한수련대한한방소아과학회 · 대한한방소아과학회지2014 · 제28권 제3호얼굴아토피 피부염환자 45명의 한의학적 치료효과에 대한 후향적 연구박건, 서산, 이정환, 장진영, 한수련대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2014 · 제27권 제2호영유아 아토피피부염 환자의 스테로이드 외용제 사용유무에 따른 한의학적 치료효과에 대한 후향적 연구박건, 서산, 양윤홍, 조아라, 한수련대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2016 · 제29권 제4호선태, 백지 외 10종 한약재 추출물 함유 외용한약의아토피 피부염 치료효과에 대한 후향적 연구박규정, 신상호, 윤영희, 이은지, 조현정, 최연길, 최예용대한한방안이비인후피부과학회 · 한방안이비인후피부과학회지2018 · 제31권 제2호

이 간행물의 다른 논문 (15건)

복분자의 항산화 및 광독성 억제활성에 미치는 영향김희택, 이인수, 김용민pp. 1-10희첨 추출물이 B16F10 세포에서 Melanin 생성과 Tyrosinase 활성에 미치는 억제효과박수연, 김종한, 최정화, 김지수, 정민영pp. 11-22加味潤燥湯이 LPS로 유도된 RAW 264.7 대식세포에서의 항염 효과 연구최종민, 김희택, 김용민pp. 23-31일당귀 에탄올 추출물의 Hyaluronic Acid 합성 효과에 대한 실험적 연구하헌용, 김희택, 강민서pp. 32-40玫瑰花 에탄올추출물이 α-MSH로 유도된 과색소 형성 억제와 작용기전 연구우원홍, 이진호, 임규상, 문연자, 강석훈, 인명희pp. 41-52
원문 보기